Royal Philips: Philips delivers solid comp sales growth, margin in 2Q reiterates FY comp sales growth outlook; adj EBITA, free

Royal Philips reported solid comparable sales growth in the second quarter of 2026, reaffirming its full-year outlook for comparable sales growth. The company noted continued momentum across its key markets, driven by strong performance in its medical imaging and personal health segments. Philips also highlighted progress in margin expansion, with adjusted EBITA margin performance in line with expectations for the quarter.

The company reiterated its full-year guidance for comparable sales growth, citing ongoing demand for its healthcare solutions and the successful execution of its strategic initiatives. Free cash flow generation remained robust, reflecting disciplined cost management and operational efficiency. Philips emphasized its commitment to long-term value creation through innovation and market diversification.

The second-quarter results underscore the company’s resilience amid macroeconomic challenges and reinforce confidence in its strategic direction. Investors will be watching closely for further progress in margin expansion and cash flow generation as the company advances its transformation initiatives.